Walleye Capital’s Medpace MEDP Stock Holding History

Walleye Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Sell	351 -5,644	-94%	-$2.6M	﹤0.01%	3556
2026 Q1	$2.88M	Sell	5,995 -3,162	-35%	-$1.62M	0.01%	1180
2025 Q4	$5.14M	Buy	+9,157	New	+$5.2M	0.02%	1134
2025 Q3	–	Sell	-190	Closed	-$59.6K	–	4871
2025 Q2	$59.6K	Buy	+190	New	+$57K	﹤0.01%	3979
2024 Q3	–	Sell	-1,664	Closed	-$685K	–	5649
2024 Q2	$685K	Buy	1,664 +980	+143%	+$388K	﹤0.01%	3211
2024 Q1	$276K	Sell	684 -1,619	-70%	-$569K	﹤0.01%	3726
2023 Q4	$706K	Buy	+2,303	New	+$622K	﹤0.01%	2664
2023 Q2	–	Sell	-1,995	Closed	-$375K	–	4653
2023 Q1	$375K	Buy	+1,995	New	+$413K	0.01%	1943
2021 Q4	–	Sell	-2,041	Closed	-$386K	–	2230
2021 Q3	$386K	Buy	+2,041	New	+$372K	0.01%	903

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Walleye Capital's MEDP Position: Q2 2026 in Review

Walleye Capital reduced its Medpace (MEDP) stake by 94% in Q2 2026, selling an estimated $2.6M and leaving 351 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

Walleye Capital first reported a position in MEDP in Q3 2021 and has held it in 9 quarters since. The position peaked at $5.14M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Walleye Capital held 351 shares of Medpace worth $186K as of Q2 2026.
Walleye Capital sold 5,644 Medpace shares in Q2 2026, an estimated $2.6M.
Medpace made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3556 holding.
Walleye Capital first reported a position in Medpace in Q3 2021 and has held it in 9 quarters since.
Walleye Capital's Medpace position peaked at $5.14M in Q4 2025.
695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.